Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.53Latest market snapshot
Implied fair value · at SKLZ's multiple
$443.40918.6% above market
12.37 SUPN revenue / share×35.85x SKLZ P/S=$443.40
Market $43.53Implied $443.40
SKLZ · current priceP/S 35.85x
$10.13Latest market snapshot
Implied fair value · at SUPN's multiple
$23.57132.6% above market
6.70 SKLZ revenue / share×3.52x SUPN P/S=$23.57
Market $10.13Implied $23.57